抗瓜氨酸化蛋白/肽抗体与类风湿关节炎左心室结构和功能的关联
在无临床心血管疾病的RA患者中,采用Bio-Plex珠式检测特定ACPA,并与心脏磁共振衍生的左心室指标进行横断面关联分析;在第二个独立RA队列中用3D超声心动图验证。两个队列均显示抗瓜氨酸化纤维蛋白原和抗瓜氨酸化波形蛋白抗体水平较高与调整后平均左心室质量指数(LVMI)升高相关,而抗瓜氨酸化双糖链蛋白聚糖抗体在队列1中与较低LVMI相关、队列2未重复。
要点
- 抗瓜氨酸化纤维蛋白原和波形蛋白抗体水平较高与调整后平均LVMI升高相关。
- 抗瓜氨酸化双糖链蛋白聚糖抗体与LVMI的负相关仅在队列1中观察到。
- 结果提示瓜氨酸化蛋白自身免疫可能参与RA心肌重构。
核心结论
- 靶向瓜氨酸化纤维蛋白原和波形蛋白肽或蛋白的抗体水平较高与两个RA队列中调整后平均LVMI升高相关。
研究设计与样本
- 队列1纳入76例无临床心血管疾病的RA患者,用定制Bio-Plex珠式检测特定ACPA,并与心脏磁共振衍生的LV指标进行横断面关联分析。
- 队列2为独立RA队列(n=74),用扩展ACPA panel和3D超声心动图评估LV指标进行验证。
- 高ACPA水平定义为≥75百分位。
主要发现
- 队列1中,抗瓜氨酸化纤维蛋白原41-60和抗瓜氨酸化波形蛋白抗体水平较高者调整后平均LVMI分别高10%和6%(P<0.05)。
- 队列1中,抗瓜氨酸化双糖链蛋白聚糖247-266抗体水平较高者调整后平均LVMI低13%(P<0.001)。
- 队列2中,抗瓜氨酸化纤维蛋白原556-575和抗瓜氨酸化波形蛋白58-77抗体水平较高者调整后平均LVMI分别高19%和15%(P<0.05)。
- 队列2中未发现抗瓜氨酸化双糖链蛋白聚糖抗体与LVMI的关联。
关键数值与推荐
- 高ACPA水平定义为≥75百分位。
- 队列1(n=76):抗瓜氨酸化纤维蛋白原41-60抗体较高与调整后平均LVMI高10%相关(P<0.05)。
- 队列1(n=76):抗瓜氨酸化波形蛋白抗体较高与调整后平均LVMI高6%相关(P<0.05)。
- 队列1(n=76):抗瓜氨酸化双糖链蛋白聚糖247-266抗体较高与调整后平均LVMI低13%相关(P<0.001)。
- 队列2(n=74):抗瓜氨酸化纤维蛋白原556-575和抗瓜氨酸化波形蛋白58-77抗体较高分别与调整后平均LVMI高19%和15%相关(P<0.05)。
临床怎么用
- 对无临床心血管疾病的RA患者,检测抗瓜氨酸化纤维蛋白原和波形蛋白抗体可能有助于识别左心室质量指数升高、潜藏心力衰竭风险者。
- 抗瓜氨酸化双糖链蛋白聚糖抗体与LVMI的负相关未在验证队列重复,暂不宜作为临床解读依据。
局限性
- 研究为横断面设计,无法推断ACPA与LVMI变化的因果关系。
- 两个队列样本量均较小(n=76和n=74)。
- 队列1与队列2所用ACPA检测 panel 和LV评估方法不同,部分抗体关联未在队列2重复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: High levels of ACPAs in RA are associated with more severe arthritis and worse prognosis. However, the role of ACPAs in mediating the increased risk of heart failure in RA remains undefined. We examined whether specific ACPAs were associated with subclinical left ventricular (LV) phenotypes that presage heart failure. METHODS: Sera from RA patients without clinical cardiovascular disease were assayed for specific ACPAs using a custom Bio-Plex bead assay, and their cross-sectional associations with cardiac magnetic resonance-derived LV measures were evaluated. High ACPA level was defined as ⩾ 75th percentile. Findings were assessed in a second independent RA cohort with an expanded panel of ACPAs and LV measures assessed by 3D-echocardiography. RESULTS: In cohort 1 (n = 76), higher levels of anti-citrullinated fibrinogen 41-60 and anti-citrullinated vimentin antibodies were associated with a 10 and 6% higher adjusted mean LV mass index (LVMI), respectively, compared with lower antibody levels (P < 0.05). In contrast, higher levels of anti-citrullinated biglycan 247-266 were associated with a 13% lower adjusted mean LVMI compared with lower levels (P < 0.001). In cohort 2 (n = 74), the association between ACPAs targeting citrullinated fibrinogen and citrullinated vimentin peptides or protein and LVMI was confirmed: higher anti-citrullinated fibrinogen 556-575 and anti-citrullinated vimentin 58-77 antibody levels were associated with a higher adjusted mean LVMI (19 and 15%, respectively; P < 0.05), but no association with biglycan was found. CONCLUSION: Higher levels of antibodies targeting citrullinated fibrinogen and vimentin peptides or protein were associated with a higher mean LVMI in both RA cohorts, potentially implicating autoimmune targeting of citrullinated proteins in myocardial remodelling in RA.
引用
- Geraldino-Pardilla L, Russo C, Sokolove J, et al. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. Rheumatology (Oxford). 2017. PMID: 27994093. doi:10.1093/rheumatology/kew436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。